Trials / Conditions / Non-small-cell Lung Cancer (NSCLC) Stage IV
Non-small-cell Lung Cancer (NSCLC) Stage IV
3 registered clinical trials studyying Non-small-cell Lung Cancer (NSCLC) Stage IV.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | A Study to Evaluate the Safety and Efficacy of Ex Vivo Expanded Autologous Immune Killer Cells (IKC) in Stage NCT03499834 | Ivy Life Sciences, Co., Ltd | Phase 2 |
| Unknown | A Phase III Trial of Recombinant Human Apo-2 Ligand for Injection NCT03083743 | Shanghai Gebaide Biotechnology Co., Ltd. | Phase 3 |
| Terminated | Phase 1 Erlotinib and Dovitinib (TKI258) in Advanced Non-small Cell Lung Cancer (NSCLC) NCT01515969 | Heather Wakelee | Phase 1 |